profit from every $100 of sales.
$0$100
STRATA Skin Sciences
$0.00+0.00% today
-100.0% in 1 year
1-year low $0.001-year high $1.71
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What STRATA Skin Sciences sold, what it kept, and what it did with the cash.
Sales went from $36.2 million in 2022 to $30.7 million in 2025, with -$6.26 million of profit last year.
SalesProfit
STRATA Skin Sciences vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| STRATA Skin Sciences | No profit yet | ||
 Boston Scientific | 22.4× · Fair price | ||
 Koninklijke Philips | 29.7× · Fair price | ||
 Steris | 31.9× · Expensive | ||
 Zimmer Biomet Holdings | 28.8× · Fair price |
AI analysis
An AI analyst reads STRATA Skin Sciences's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 36 | 33 | 34 | 31 | |
| 22 | 18 | 19 | 18 | |
| -5 | -6 | -5 | -6 | |
| 1 | -3 | -3 | 0 | |
| -6 | -11 | -10 | -6 | |
| -1.60 | -3.10 | -2.65 | – | |
| 60.2% | 55.3% | 57.3% | 58.3% | |
| -12.9% | -18.9% | -14.9% | -19.0% | |
| -15.3% | -32.5% | -30.1% | -20.4% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 52 | 42 | 35 | 31 |
| Cash | 5 | 7 | 7 | 8 |
| Total debt | 8 | 16 | 16 | 16 |
| Total liabilities | 30 | 29 | 30 | 28 |
| 22 | 13 | 5 | 3 | |
| 3 | 3 | 4 | – | |
| -11.9% | -25.9% | -30.1% | -17.7% | |
| -25.4% | -85.4% | -202.9% | -215.3% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -1 | -1 | 0 | -3 | |
| 4 | 5 | 2 | 1 | |
| -5 | -6 | -1 | -4 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 1 | 1 | 0 | 1 |
Valuation
- –
- –
- –
- 0.3×
- 0.0×
- –
- 47.2×
- -724,829.9%
- -1,064,795.9%
- 0.0%
Profitability
- 58.3%
- -19.0%
- -20.4%
- -1.8%
- -31.7%
- -28.9%
- -360.3%
- -21.2%
- -160.3%
- 1.4%
Growth
- −5.3%
- –
- −194.3%
- –
- +8.1%
Financial health
- 47.2×
- 5.59
- 53.3%
- -3.1×
- 0.58
- 0.48
- 1.01
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 16%of 953
Bottom 12%of 877
Bottom 10%of 871
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Mar 25, 2026 | 0.13 | -0.26 | +150.0% |
| Nov 13, 2025 | -0.36 | -0.26 | −38.5% |
| Aug 13, 2025 | -0.60 | -0.24 | −150.0% |
| May 14, 2025 | -0.58 | -0.52 | −11.5% |
| Mar 27, 2025 | -1.13 | -0.30 | −276.7% |
| Nov 13, 2024 | -0.53 | -0.44 | −20.5% |
| Aug 14, 2024 | -0.03 | -0.70 | +95.7% |
| May 15, 2024 | -1.00 | -0.07 | −1,328.6% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
27No pass
Benjamin Graham
36No pass
Philip Fisher
33No pass
Peter Lynch
0No pass
Joel Greenblatt
0No pass
Charlie Munger
16No pass
Terry Smith
16No pass
Questions about STRATA Skin Sciences
Is STRATA Skin Sciences a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the STRATA Skin Sciences AI analysis
What does STRATA Skin Sciences do?
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It is in Medical - Devices.
Does STRATA Skin Sciences pay a dividend?
No. STRATA Skin Sciences does not pay a dividend at the moment.
Is STRATA Skin Sciences stock halal?
No. STRATA Skin Sciences does not pass our halal screen: its debt is 2,766,667% of its market value, at or above the 33% limit. How we check
How has STRATA Skin Sciences stock done over the past year?
Down 100.0% over the past twelve months, to $0.00. It traded between $0.00 and $1.71 and is 100.0% below its high.
Who are STRATA Skin Sciences's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with STRATA Skin Sciences's.
Prices: daily closes to Nov 9, 2026. Fundamentals: company reports via invest-like data.